After a month of owning MusclePharm…has FitLife Brands given us any hints of what’s to come next? For those unaware, the supplement brands that are within the FitLife Brands portfolio are categorized in three segments…NDS Products (which are a collection of brands mostly sold in the GNC franchise system), iSatori Products (which are a collection of brands sold through a diversified retail mix), and the recently acquired Amazon-focused brands within Mimi’s Rock Corporation. In total, the FitLife Brands portfolio is sold through more than 20,000 retail locations globally. In the third quarter of 2023, FitLife Brands Inc. (NASDAQ: FTLF) had revenues of $13.9 million…which was up 67% YoY (yet all quarterly growth plus more was attributed to the February 2023 acquisition of Mimi's Rock affecting the comparatives). In a short amount of time post-acqusition of Mimi's Rock, FitLife Brands has been able to cut around $3.5 million in annualized SG&A costs. This strategic activity confirms what I’ve stated in the past about the company being sound operators that lean towards fiscal conservatism, but I’m still a bit weary on how this will play out with adding in MusclePharm, a second “major” acquisition that happened within about eight months. FitLife Brands officially closed the $18.5 million acquisition of the bankrupt MusclePharm on October 10, 2023. So, are we to expect that FitLife Brands will utilize the same Mimi’s Rock integration gameplan with MusclePharm? In this content, I'll predict the likely strategic turnaround plan at MusclePharm that includes rebuilding the Assault pre-workout platform and refining the Combat protein platform. While it’s silly to believe that MusclePharm won’t require a whole bunch of energy put towards turnaround efforts, I think FitLife Brands leadership is underselling its potential in 2024.

FOLLOW ME ON MY SOCIAL MEDIA ACCOUNTS